Evidence map›Paper›PMID 30845751›Full record

ReviewInternational journal of molecular sciences2019

An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.

Shi-Hui Law, Mei-Lin Chan, Gopal K Marathe, Farzana Parveen, Chu-Huang Chen, Liang-Yin Ke

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 432 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
432citing papers in PubMed, 1 pooled it
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

432 citing papers in PubMed, 1 synthesis or guideline pooled it, 781 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. MSTNCells · 2026
    Article
  9. Article
  10. Article
  11. Lipidomic predictors of residual insulin production in adults with newly diagnosed type 1 diabetes.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

372 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Shi-Hui LawDepartment of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. shlaw_0909@hotmail.com.
Mei-Lin ChanCenter for Lipid Biosciences, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. mlchan127@gmail.com.
Gopal K MaratheDepartment of Studies in Biochemistry, Manasagangothri, University of Mysore, Mysore-570006, India. marathe1962@gmail.com.
Farzana ParveenDepartment of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. farzanaparveen@zoho.com.
Chu-Huang ChenCenter for Lipid Biosciences, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. cchen@texasheart.org.
Liang-Yin KeDepartment of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. kly@kmu.edu.tw.
Kaohsiung Medical University · TWUniversity of Mysore · IN

Funding

MECHANISM FOR PRESSURE COLLAPSE WITHOUT FIBRILLATIONR01HL064050 · NHLBI · UNIVERSITY OF MEMPHIS · PI MALKIN, ROBERT A · 2000 to 2002
$636k
Kaohsiung Medical University KMU-DK107012Kaohsiung Medical University KMU-TP105D14Ministry of Science and Technology, Taiwan 105-2320-B-037-004-MY3Ministry of Science and Technology, Taiwan 106-2314-B-037-069-Ministry of Science and Technology, Taiwan 107-2321-B-037-002-Texas Heart Institute 765-64050
6 · The paper itself

Abstract

Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively associated with cardiovascular and neurodegenerative diseases. However, findings from recent clinical lipidomic studies of LPC have been controversial. A key issue is the complexity of the enzymatic cascade involved in LPC metabolism. Here, we address the coordination of these enzymes and the derangement that may disrupt LPC homeostasis, leading to metabolic disorders. LPC is mainly derived from the turnover of phosphatidylcholine (PC) in the circulation by phospholipase A₂ (PLA₂). In the presence of Acyl-CoA, lysophosphatidylcholine acyltransferase (LPCAT) converts LPC to PC, which rapidly gets recycled by the Lands cycle. However, overexpression or enhanced activity of PLA₂ increases the LPC content in modified low-density lipoprotein (LDL) and oxidized LDL, which play significant roles in the development of atherosclerotic plaques and endothelial dysfunction. The intracellular enzyme LPCAT cannot directly remove LPC from circulation. Hydrolysis of LPC by autotaxin, an enzyme with lysophospholipase D activity, generates lysophosphatidic acid, which is highly associated with cancers. Although enzymes with lysophospholipase A₁ activity could theoretically degrade LPC into harmless metabolites, they have not been found in the circulation. In conclusion, understanding enzyme kinetics and LPC metabolism may help identify novel therapeutic targets in LPC-associated diseases.

Indexed as

1-Acylglycerophosphocholine O-AcyltransferaseHomeostasisHumansHydrolysisLipoproteins, LDLLysophosphatidylcholinesLysophospholipase DMetabolic DiseasesPhosphatidylcholinesPhospholipases A2Phosphoric Diester Hydrolases1-Acylglycerophosphocholine O-AcyltransferaseLipoproteins, LDLLysophosphatidylcholinesLysophospholipase DPhosphatidylcholinesPhospholipases A2Phosphoric Diester HydrolasesautotaxinG protein–coupled receptor G2Alipoprotein-associated phospholipase A2lysophosphatidylcholinelysophosphatidylcholine acyltransferaselysophospholipase A1

Identifiers

PMID30845751
PMCPMC6429061
OpenAlexW2919002166

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.